Detalles de la búsqueda
1.
IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer.
Int J Cancer
; 146(8): 2348-2359, 2020 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31490549
2.
Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequences.
Br J Cancer
; 119(7): 832-839, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30287915
3.
Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancer.
Pharmacol Res
; 128: 122-129, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28827188
4.
Evaluation of KDR rs34231037 as a predictor of sunitinib efficacy in patients with metastatic renal cell carcinoma.
Pharmacogenet Genomics
; 27(6): 227-231, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28430711
5.
Genotypes of CYP2C8 and FGD4 and their association with peripheral neuropathy or early dose reduction in paclitaxel-treated breast cancer patients.
Br J Cancer
; 115(11): 1335-1342, 2016 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27736846
6.
A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer.
Br J Cancer
; 115(8): 940-948, 2016 10 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27575850
7.
Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma.
Eur J Clin Pharmacol
; 71(12): 1477-84, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26387812
8.
Proteomics of genetically engineered mouse mammary tumors identifies fatty acid metabolism members as potential predictive markers for cisplatin resistance.
Mol Cell Proteomics
; 12(5): 1319-34, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23397111
9.
Adherence and patients' experiences with the use of oral anticancer agents.
Acta Oncol
; 53(2): 259-67, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24266637
10.
Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with potential diagnostic and prognostic value in human breast cancer.
Mol Cell Proteomics
; 11(7): M111.013334, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22366898
11.
Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Oncol
; 9(10): 1381-1389, 2023 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37561451
12.
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer.
J Exp Med
; 220(11)2023 11 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37642941
13.
Sunitinib-induced changes in circulating endothelial cell-related proteins in patients with metastatic renal cell cancer.
Int J Cancer
; 131(4): E484-93, 2012 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21953673
14.
Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging.
Hum Brain Mapp
; 33(12): 2971-83, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22095746
15.
Use and costs of oral anticancer agents in the Netherlands in the period 2000-2008.
Pharmacoepidemiol Drug Saf
; 21(10): 1036-44, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21956857
16.
SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation.
BMC Surg
; 12: 5, 2012 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-22469291
17.
Genome-Wide Meta-Analysis Identifies Variants in DSCAM and PDLIM3 That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib.
Cancers (Basel)
; 14(12)2022 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35740506
18.
Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.
Hum Brain Mapp
; 32(8): 1206-19, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20669165
19.
The use of erlotinib in daily practice: a study on adherence and patients' experiences.
BMC Cancer
; 11: 284, 2011 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21722354
20.
Reduction in skin microvascular density and changes in vessel morphology in patients treated with sunitinib.
Anticancer Drugs
; 21(4): 439-46, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20051825